Preventing the Spread of COVID-19 and Maintaining Production and Product Supply
First written in FY2020. 12 of 14 entries say "Restated". Latest entry: FY2026-H1.
The whole theme swung hardest in 2026: 1 of 12 companies on the "Worse" side.
108 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「The Company has continued expanding sales of specimen testing equipment, offering both handheld and desktop models. Despite the impact of higher raw-material costs, it has continued working to maintain a stable supply of consumables and other products.」
The Company continues to expand sales of handheld and desktop specimen testing equipment and maintain a stable supply of consumables and other products amid higher raw-material costs. No new specific measures for preventing the spread of infection or maintaining the production system have been indicated. - FY2024-Q2RestatedAnnual report
「Against this operating backdrop, we further strengthened R&D activities related to our core blood collection tube preparation equipment and associated systems, worked to enhance the solutions we can provide, expanded sales of compact, high-performance new specimen testing equipment, and continued efforts to ensure a stable supply of consumables and other products.」
The Company continues to expand solutions for medical facilities and maintain a stable supply of consumables and other products. No new specific measures for preventing the spread of infection or maintaining the production system have been indicated. - FY2024-Q1RestatedAnnual report
「Against this operating backdrop, we further strengthened R&D activities related to our core blood collection tube preparation equipment and associated systems, worked to enhance the solutions we can provide, expanded sales of compact, high-performance new specimen testing equipment, and continued efforts to ensure a stable supply of consumables and other products.」
The Company continues to expand solutions for medical facilities and maintain a stable supply of consumables and other products. No new specific measures for preventing the spread of infection or maintaining the production system have been indicated. - FY2023RestatedAnnual report
「Specifically, the Company continues to implement measures prioritizing safety and the prevention of infection, including providing customers with splash-prevention sheets for infection control, offering a reservation blood-collection control option for blood collection tube preparation equipment and systems that helps avoid the three Cs in hospitals, and using telework, working from home and staggered working hours in its internal departments. At its production sites, the Company is also working to maintain production while thoroughly implementing infection-control measures and is focusing on maintaining a stable supply of products to medical institutions.」
The Company continues infection-control and stable-supply measures, including splash-prevention sheets, the reservation blood-collection control option, telework, staggered working hours and the maintenance of production. - FY2023-Q3RestatedAnnual report
「Against this backdrop, the company continued to focus on sales activities for blood collection tube preparation systems and related systems that contribute to the stable and efficient operation of healthcare facilities, while expanding the range of solutions it can provide, and continued proposing the introduction of laboratory analyzers and working to ensure a stable supply of consumables and other products.」
The Company continues to expand solutions for medical facilities, propose the introduction of specimen testing equipment and maintain a stable supply of consumables and other products. No new specific measures for preventing the spread of infection or maintaining the production system have been indicated. - FY2023-Q2RestatedAnnual report
「Against this backdrop, the company continued to focus on sales activities for blood collection tube preparation systems and related systems that contribute to the stable and efficient operation of healthcare facilities, while expanding the range of solutions it can provide, and continued proposing the introduction of laboratory analyzers and working to ensure a stable supply of consumables.」
While addressing COVID-19, the Company continues to propose the introduction of various types of equipment for medical facilities and maintain a stable supply of consumables. No new specific measures for preventing the spread of infection or maintaining the production system have been indicated. - FY2023-Q1RestatedAnnual report
「Against this backdrop, the company continued to focus on sales activities for blood collection tube preparation systems and related systems that contribute to the stable and efficient operation of healthcare facilities, while expanding its equipment lineup and range of systems, and continued proposing the introduction of laboratory analyzers and working to ensure a stable supply of consumables and other products.」
While addressing COVID-19, the Company continues to propose the introduction of various types of equipment for medical facilities and maintain a stable supply of consumables and other products. No new specific measures for preventing the spread of infection or maintaining the production system have been indicated. - FY2022RestatedAnnual report
「Specifically, the Company continues to implement measures prioritizing safety and the prevention of infection, including providing customers with splash-prevention sheets for infection control, offering a reservation blood-collection control option for blood collection tube preparation equipment and systems that helps avoid the three Cs in hospitals, and using telework, working from home and staggered working hours in its internal departments. At its production sites, the Company is also working to maintain production while thoroughly implementing infection-control measures and is focusing on maintaining a stable supply of products to medical institutions.」
The Company continues infection-control and stable-supply measures, including splash-prevention sheets, the reservation blood-collection control option, telework, staggered working hours and the maintenance of production. - FY2022-Q2RestatedAnnual report
「Against this backdrop, the company continued proposing the introduction of blood collection tube preparation systems and related systems and laboratory analyzers that contribute to the safe and stable operation of healthcare facilities, while continuing to focus on ensuring a stable supply of the consumables used with these products.」
While addressing COVID-19, the Company continues to propose the introduction of various types of equipment for medical facilities and maintain a stable supply of related consumables. No new specific measures for preventing the spread of infection or maintaining the supply system have been indicated. - FY2022-Q1RestatedAnnual report
「Against this backdrop, while responding to COVID-19, the company continued proposing the introduction of blood collection tube preparation systems and related systems and laboratory analyzers that contribute to the stable operation of healthcare facilities, while working to ensure a stable supply of the consumables used with these products.」
While addressing COVID-19, the Company continues to propose the introduction of various types of equipment for medical facilities and maintain a stable supply of consumables. No new specific measures for preventing the spread of infection or maintaining the production system have been indicated. - FY2021AdvancedAnnual report
「Specifically, the Company continues to implement measures prioritizing safety and the prevention of infection, including providing customers with splash-prevention sheets for infection control, offering a reservation blood-collection control option for blood collection tube preparation equipment and systems that helps avoid the three Cs in hospitals, and using telework, working from home and staggered working hours in its internal departments.」
In addition to the existing splash-prevention sheets, telework, staggered working hours and production-maintenance measures, the Company has specifically identified a reservation blood-collection control option that helps avoid the three Cs in hospitals. - FY2021-Q3RestatedAnnual report
「In this business environment, the Company has continued to maintain a stable supply of consumables to users while proposing the introduction of blood collection tube preparation equipment and related systems, as well as specimen testing equipment, to support the operation of testing departments at medical facilities.」
The Company continues to maintain a stable supply of consumables and propose the introduction of various types of equipment supporting testing departments at medical facilities. No material changes have been indicated in measures to prevent the spread of infection or maintain product supplies. - FY2021-Q1RestatedAnnual report
「In this business environment, the Company has continued proposing blood collection tube preparation equipment and related systems, as well as specimen testing equipment, to support the operation of testing departments at medical facilities, while working to secure a stable supply system for consumables and other products.」
The Company continues to secure a stable supply system for consumables and propose products that support testing departments at medical facilities. No material changes have been indicated in measures to prevent the spread of COVID-19 or maintain product supplies. - FY2020First statedAnnual report
「The Company is currently implementing a range of measures to prevent the spread of infectious diseases, with the safety and health of all stakeholders as its highest priority. Specifically, it is providing customers with splash-prevention sheets for infection control and implementing measures focused on ensuring safety and preventing the spread of infection, including teleworking, working from home and staggered working hours in its internal departments. At its production sites, the Company is also working to maintain production by thoroughly implementing infection-control measures, including operating in two teams, and is focusing on maintaining a stable supply of products to medical institutions.」
The Company is providing splash-prevention sheets, implementing telework, working from home and staggered working hours, and operating production sites in two teams as infection-control measures, with the aim of maintaining a stable supply of products to medical institutions.